Cargando…
Severe Acute Respiratory Syndrome–associated Coronavirus in Lung Tissue
Efforts to contain severe acute respiratory syndrome (SARS) have been limited by the lack of a standardized, sensitive, and specific test for SARS-associated coronavirus (CoV). We used a standardized reverse transcription-polymerase chain reaction assay to detect SARS-CoV in lung samples obtained fr...
Autores principales: | Mazzulli, Tony, Farcas, Gabriella A., Poutanen, Susan M., Willey, Barbara M., Low, Donald E., Butany, Jagdish, Asa, Sylvia L., Kain, Kevin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322746/ https://www.ncbi.nlm.nih.gov/pubmed/15078592 http://dx.doi.org/10.3201/eid1001.030404 |
Ejemplares similares
-
Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses
por: Hadjinicolaou, Andreas V., et al.
Publicado: (2011) -
Pulmonary pathology of severe acute respiratory syndrome in Toronto
por: Hwang, David M, et al.
Publicado: (2005) -
Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections
por: Matic, Nancy, et al.
Publicado: (2017) -
Prospective Evaluation of Accelerate Pheno™ System (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) from Positive Blood Cultures (+BC) using AXDX PhenoTest™ BC Kits
por: Willey, Barbara M, et al.
Publicado: (2017) -
Treatment and vaccines for severe acute respiratory syndrome
por: Groneberg, David A, et al.
Publicado: (2005)